English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Columbia University review finds unequal access to fertility preservation for young female cancer patients

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Evaluate forecasts Lilly’s tirzepatide to surpass $70B in sales by 2032

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Zebrafish study finds visual environment shapes retina development and behavior

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Panel discusses future of US public health system after major federal layoffs

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Experts to discuss advancements in antibody-drug conjugates at BIO International Convention

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Experts say no evidence menstrual cups improve chances of conception

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Biopharma dealmakers weigh contract changes amid Trump’s Most Favored Nation drug pricing policy

+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Researchers identify new mechanism amplifying KIT activity in gastrointestinal stromal tumors

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily